SPOTLIGHT: Artemis to construct mice

Germany's Artemis Pharmaceuticals GmbH has signed a research agreement with Merck to construct a large number of shRNA interference--genetically engineered mouse models. Release

Suggested Articles

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.

The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.